Brexit – Implications for the Life Sciences Industry
Join the next Women’s Life Sciences Network event featuring a panel discussion regarding the impact of Brexit on the life sciences industry. Our distinguished panelists will address the potential regulatory implications of a “divorce” deal and how Brexit is already impacting a global pharmaceutical company. They will also discuss the current status of negotiations and how industry is involved in this process.
- Stephanie Lane, Director Public Policy, MSD Europe Inc.
- Sini Eskola, Director Regulatory Affairs, EFPIA
- Elizabeth Kuiper, Director European Affairs, EFPIA
Click here to view biographies of the panelists.
We hope you will join us for this interesting discussion, followed by a networking reception.
For more information or questions, please contact Cristina Menendez Ruiz at +32 2 504 64 53 or at email@example.com.
Click here to join the Women’s Life Sciences Network LinkedIn Group.
All Women’s Life Sciences Network events are free of charge to participants and receive no funding from industry.